Evaluation of the Impact of Direct Conversation With Patients in the Compliance With the "Split-dose" Regimen Preparation for Colonoscopy Scheduled in the First Part of the Morning
NCT ID: NCT02638558
Last Updated: 2016-09-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
286 participants
INTERVENTIONAL
2016-01-31
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Still, there are some issues about compliance and tolerability with split-dose regimens. Two recent prospective works have shown that only a small number of patients (33%) chooses the split-dose regimen when the colonoscopy is scheduled before 10 a.m. and when patients are forced to used the split-dose, 1/7 did not comply with it, especially if the procedure is before 10 a.m. The most common concerns are about early wake-up, travel interruption and fear of incontinence. Both these papers state that strategies to reduce this noncompliance are needed.
The investigators aim to prove whether an "active action" (an oral explanation before the colonoscopy about why split-dose regimens are better) may improve patients' compliance in endoscopies scheduled in the early morning (from 8 to 10 a.m).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bowel Prep Acceptance in Clinical Practice
NCT02287051
Evaluation of Information on Bowel Preparation for Morning Colonoscopy
NCT03650725
A Study to Investigate the Effect of a Meal At 6pm the Day Before the Colonoscopy on the Bowel Cleansing with Plenvu
NCT06651398
Barriers and Breakthroughs in IMPlementing Split Regimen OVEr Single Dose
NCT03581175
The Clinical Acceptability of Unsedated Colonoscopy
NCT01434927
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
written + oral explanation
patients will undergo both written and oral explanation for preparation with split dose
written + oral explanation
written explanation
patients will receive only a written explanation for preparation with split dose
written explanation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
written + oral explanation
written explanation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* contraindications in drinking the preparation
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Valduce Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alida Andrealli
MD
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
04/2015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.